Big round · 27 August 2026
A
AusperBio Therapeutics raises $120M Series C led by Harbert Growth Partners
AusperBio Therapeutics, based in United States, has raised $120M in a Series C led by Harbert Growth Partners, announced on 27 August 2026. 7 other investors joined. It is the 375th largest equity round we recorded in the twelve months to that date, and the 74th largest Series C of 199.
Raised$120M2 sources reported it
StageSeries Cfirst round on record
Investors81 named as lead
Where USUnited States
USBiotechHealthcarePharma
How big is it?
Against every equity round we recorded in the twelve months to 27 August 2026. Ranks count companies, so the same raise reported twice is counted once.
#375equity round of the last twelve months
#74Series C of 199 in that time
#249round in United States, of 1,111
This round$120M
Median Series C$100M
1.2 times the median Series C of the last twelve months.
Who invested
Also in the round
Funding history
- August 2026Series C$120M
This is the first round we hold for the company.
Reported by
- TechStartups28 August
- Ventureburn28 August
The round's figures come from these reports; each link opens the original.
